AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4%
Fri, 2 Aug

AJANTA PHARMA has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:

AJANTA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-18*
3
Mar-19*
3
Jun-19*
QoQ ChangeYoY Change
Net SalesRs m5,1105,1526,11918.8%19.8%
Other incomeRs m811676368.7%-6.0%
TurnoverRs m5,1915,1686,19619.9%19.4%
ExpensesRs m3,5353,8814,43614.3%25.5%
Gross profitRs m1,5751,2711,68432.5%6.9%
DepreciationRs m17218822821.5%32.7%
InterestRs m2818132.5%952.9%
Profit before taxRs m1,4831,0921,51538.7%2.1%
TaxRs m42520336881.4%-13.3%
Profit after taxRs m1,0588891,14629.0%8.4%
Gross profit margin%30.824.727.5
Effective tax rate%28.718.624.3
Net profit margin%20.417.218.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 19.8% on a year-on-year (YoY) basis. The expenses were up by 25.5% YoY during the same period.
  • The company's operating profit increased by 6.9% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 27.5% in 1QFY20 as against 30.8% in 1QFY19.
  • Depreciation charges increased by 32.7% and finance costs increased by 952.9% YoY, respectively.
  • Other income declined by 6.0% YoY during the quarter.
  • Net profit for the quarter increased by 8.4% YoY. Net profit margins during the quarter declined from 20.4% in 1QFY19 to 18.5% in 1QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 18.8% on a quarter-on-quarter (QoQ) basis. The expenses were up by 14.3% QoQ during the same period.
  • The company's operating profit increased by 32.5% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.5% in 1QFY20 as against 24.7% in 4QFY19.
  • Net profit for the quarter increased by 29.0% QoQ, while net profit margins increased from 17.2% in 4QFY19 to 18.5% in 1QFY20.

To see how AJANTA PHARMA has performed over the last eight quarters,please visit here.

AJANTA PHARMA Share Price Performance

Over the last one year,AJANTA PHARMA share price has moved down from Rs 1,135.2 to Rs 942.4, registering a Loss of Rs 192.8 or around 17.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,471.0 (down 0.9%). Over the last one year it has moved down from 14,511.5 to 12,471.0, a gain of 2,041 points (down 14.1%).

Overall, the S&P BSE SENSEX is down 2.3% over the year.

Current Valuations

At the current price of Rs 942.4, the price to earnings (P/E) ratio of AJANTA PHARMA stands at 20.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.7 times.

Equitymaster requests your view! Post a comment on "AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4%". Click here!

  

Related Views on News

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9% (Quarterly Result Update)

May 3, 2019 | Updated on May 3, 2019

For the quarter ended March 2019, AJANTA PHARMA has posted a net profit of Rs 889 m (down 5.9% YoY). Sales on the other hand came in at Rs 5 bn (down 2.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 54.6% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, AJANTA PHARMA has posted a net profit of Rs 669 m (down 54.6% YoY). Sales on the other hand came in at Rs 5 bn (down 17.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Sep 13, 2019 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - CIPLA COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS